Mindray's Q2 Results Disappoint Investors: Weaker China Growth Due To Slowdown In Government Tender
This article was originally published in The Pink Sheet Daily
Executive Summary
The Chinese device maker remains optimistic about government spending over the long term, as the Chinese government has made no change to its stated three-year health care reform plan or the associated budgets for each category under the plan, exec says.
You may also be interested in...
Philips Acquires Shanghai Apex, Targets Low-End Ultrasound Market In Wake Of China Healthcare Reform
SHANGHAI - Amsterdam-based Royal Philips Electronics has acquired Shanghai Apex, an ultrasound transducer provider in China, to expand Philips' low-end ultrasound product line to take advantage of the growing device market expected from China's ongoing healthcare reforms, the company announced July 28
China Details Work Plan For Healthcare Reforms In 2010
SHANGHAI - China's State Council released April 19 a new work plan for healthcare reform, which details responsibilities of various departments under the State Council and highlights 16 main missions in 2010
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.